Opko Health (OPK) Cash from Financing Activities (2010 - 2026)

Opko Health has reported Cash from Financing Activities for 17 years, with the latest figure at -$5.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 28.22% year-over-year to -$5.2 million; the trailing twelve-month figure through Mar 2026 stood at -$119.2 million (down 145.89% YoY), and the FY2025 full-year result was -$118.1 million, down 164.1% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$5.2 million, up from -$18.3 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $224.6 million in Q3 2024, with the low at -$79.5 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged $9.5 million across 5 years, with a median of -$823000.0 in 2023.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 10571.64% — and 2025, when it sank 529.72%.
• Opko Health's Cash from Financing Activities stood at $10.1 million in 2022, then sank by 136.98% to -$3.8 million in 2023, then soared by 6088.75% to $224.6 million in 2024, then plunged by 108.16% to -$18.3 million in 2025, then surged by 71.88% to -$5.2 million in 2026.
• The last three Cash from Financing Activities figures came in at -$5.2 million (Q1 2026), -$18.3 million (Q4 2025), and -$16.2 million (Q3 2025), per Business Quant data.